knee osteoarthritis MedDRA version: 20.0 Level: LLT Classification code 10031165 Term: Osteoarthritis knee System Organ Class: 100000004859
Conditions
Interventions
Trade Name: Dexametasone
Product Name: Dexamethasone "KRKA" injektionsvæske, opløsning 4mg/ml
Product Code: 29721
Pharmaceutical Form: Infusion
INN or Proposed INN: DEXAMETHASONE DIPROPIONATE
CAS Numb
Sponsors
Aalborg University Hospital, Department of Orthopedics
Mogens Brouw Jørgensen
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: patients =65 years) yes F.1.3.1 Number of subjects for this age range 35
Exclusion criteria
Exclusion criteria: Fertil women, daily use of opioids, NSAID or glucocorticoid, allergi to medicin used in the trial,alcohol abuse, cognictive dysfunction, severe kidney or hesrt disease, language barrier, operation in generel anaesthesia
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Main Objective: Pain management i the first week after UKA;Secondary Objective: opiod use in the first week after UKA;Primary end point(s): knee pain, opioid use, knee swelling, PONV in the first week after UKA;Timepoint(s) of evaluation of this end point: one week after UKA | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary end point(s): wound complications in the first week after UKA;Timepoint(s) of evaluation of this end point: one week after UKA | — |
Countries
Denmark
Outcome results
None listed